Evidence map›Paper›PMID 32935693›Full record

ReviewNatural product reports2021

New developments in RiPP discovery, enzymology and engineering.

Manuel Montalbán-López, Thomas A Scott, Sangeetha Ramesh, Imran R Rahman, Auke J van Heel, Jakob H Viel, Vahe Bandarian, Elke Dittmann, Olga Genilloud, Yuki Goto and 26 more

Abstract readReview
In one paragraph

Review in Natural product reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 441 papers.

0numbers the graph read from it
0cells of the map it votes in
441citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

441 citing papers in PubMed.

  1. Exploring RiPP-derivedRSC chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Late-Stage Posttranslational Assembly of Fosfazinomycins.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Thiooxazole Formation on a NontypeablebioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Structure and Activity of Class II Lanthipeptides From a Thermophilic Bacterium.Chembiochem : a European journal of chemical biology · 2026
    Article
  20. Article

381 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Manuel Montalbán-LópezDepartment of Microbiology, University of Granada, Spain.
Thomas A Scott
Sangeetha Ramesh
Imran R Rahman
Auke J van Heel
Jakob H Viel
Vahe Bandarian
Elke Dittmann
Olga Genilloud
Yuki Goto
María José Grande Burgos
Colin Hill
Seokhee Kim
Jesko Koehnke
John A Latham
A James Link
Beatriz Martínez
Satish K Nair
Yvain Nicolet
Sylvie Rebuffat
Hans-Georg Sahl
Dipti Sareen
Eric W Schmidt
Lutz Schmitt
Konstantin Severinov
Roderich D Süssmuth
Andrew W Truman
Huan Wang
Jing-Ke Weng
Gilles P van Wezel
Qi Zhang
Jin Zhong
Jörn Piel
Douglas A Mitchell
Oscar P Kuipers
Wilfred A van der Donk

Funding

A Scalable Platform to Discover Antimicrobials of Ribosomal OriginR01AI144967 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Douglas Alan Mitchell, WILFRED A. VAN DER DONK · 2019 to 2026
$6.0M
Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
Enzyme Chemistry and Biological Function of RiPP-like Modifications.R01GM097142 · NIGMS · VANDERBILT UNIVERSITY · PI MITCHELL, DOUGLAS ALAN · 2012 to 2024
$4.1M
Structural /Mechanistic Study of Lantibiotic Biosynthetic Enzymes & AutoimmunityR01GM079038 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2006 to 2023
$3.7M
Posttranslational Modifications during Natural Product BiosynthesisR37GM058822 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI VAN DER DONK, WILFRED A. · 2016 to 2025
$2.9M
Genomics-Accelerated Natural Product DiscoveryR01GM123998 · NIGMS · VANDERBILT UNIVERSITY · PI MITCHELL, DOUGLAS ALAN · 2017 to 2024
$2.6M
Exploring Peptide Conjugates as Trojan Horse Systems for Drug Design and DiscoveryR01AI117210 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2016 to 2020
$2.2M
Structural Biological Studies of Thipeptide Biosynthesis and EngineeringR01GM131347 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2019 to 2022
$1.2M
Biotechnology and Biological Sciences Research Council BBS/E/J/000PR9790Howard Hughes Medical InstituteNIAID NIH HHS R01 AI117210NIAID NIH HHS R01 AI144967NIGMS NIH HHS R01 GM079038NIGMS NIH HHS R01 GM097142NIGMS NIH HHS R01 GM123998NIGMS NIH HHS R01 GM131347NIGMS NIH HHS R37 GM058822NIGMS NIH HHS T32 GM070421
6 · The paper itself

Abstract

Covering: up to June 2020Ribosomally-synthesized and post-translationally modified peptides (RiPPs) are a large group of natural products. A community-driven review in 2013 described the emerging commonalities in the biosynthesis of RiPPs and the opportunities they offered for bioengineering and genome mining. Since then, the field has seen tremendous advances in understanding of the mechanisms by which nature assembles these compounds, in engineering their biosynthetic machinery for a wide range of applications, and in the discovery of entirely new RiPP families using bioinformatic tools developed specifically for this compound class. The First International Conference on RiPPs was held in 2019, and the meeting participants assembled the current review describing new developments since 2013. The review discusses the new classes of RiPPs that have been discovered, the advances in our understanding of the installation of both primary and secondary post-translational modifications, and the mechanisms by which the enzymes recognize the leader peptides in their substrates. In addition, genome mining tools used for RiPP discovery are discussed as well as various strategies for RiPP engineering. An outlook section presents directions for future research.

Indexed as

Biological ProductsComputational BiologyEnzymesHydroxylationMethylationPeptidesPhosphorylationProtein EngineeringProtein Processing, Post-TranslationalProtein Sorting SignalsRibosomesBiological ProductsEnzymesPeptidesProtein Sorting Signals

Identifiers

PMID32935693
PMCPMC7864896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.